4.6 Article

Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis

Journal

ORAL ONCOLOGY
Volume 71, Issue -, Pages 11-15

Publisher

ELSEVIER
DOI: 10.1016/j.oraloncology.2017.05.018

Keywords

Low-level laser therapy; Oral mucositis; Head and neck cancer; Radiotherapy; Chemotherapy; Overall survival; Disease-free survival; Progression-free survival

Ask authors/readers for more resources

Background: The impact of low-level laser therapy (LLLT) to prevent oral mucositis in patients treated with exclusive chemoradiation therapy remains unknown. This study evaluated the overall, diseasefree and progression-free survival of these patients. Methods: Overall, disease-free and progression-free survival of 94 patients diagnosed with oropharynx, nasopharynx, and hypopharynx cancer, who participated on a phase III study, was evaluated from 2007 to 2015. The patients were subjected to conventional radiotherapy plus cisplatin every 3 weeks. LLLT was applied with an InGaAlP diode (660 nm-100 mW-1 J-4 J/cm(2)). Results: With a median follow-up of 41.3 months (range 0.7-101.9), patients receiving LLLT had a statistically significant better complete response to treatment than those in the placebo group (LG = 89.1%; PG = 67.4%; p = 0.013). Patients subjected to LLLT also displayed increase in progression-free survival than those in the placebo group (61.7% vs. 40.4%; p = 0.030; HR: 1: 93; CI 95%: 1.07-3.5) and had a tendency for better overall survival (57.4% vs. 40.4%; p = 0.90; HR: 1.64; CI 95%: 0.92-2.91). Conclusion: This is the first study to suggest that LLLT may improve survival of head and neck cancer patients treated with chemoradiotherapy. Further studies, with a larger sample, are necessary to confirm our findings. (C) 2017 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Dentistry, Oral Surgery & Medicine

Lessening COVID-19 healthcare burden in dental practice via rapid serological tests

Daniel Cohen Goldemberg, Andreia Cristina de Melo, Livia Cristina de Melo Pino, Heliton Spindola Antunes, Jair Carneiro Leao, Stephen Porter

ORAL DISEASES (2022)

Article Dentistry, Oral Surgery & Medicine

Epidemiology of tongue squamous cell carcinoma: A retrospective cohort study

Ana Carolina da Silva Souto, Fernanda Vieira Heimlich, Leticia Lima de Oliveira, Anke Bergmann, Fernando Luiz Dias, Heliton Spindola Antunes, Andreia Cristina de Melo, Luiz Claudio Santos Thuler, Daniel Cohen Goldemberg

Summary: This study retrospectively analyzed the epidemiological characteristics and specific survival of patients diagnosed with tongue squamous cell carcinoma at the National Cancer Institute. The results showed that the majority of patients were male, smokers, alcohol consumers, had low education, and were diagnosed at an advanced stage, with poor specific survival.

ORAL DISEASES (2023)

Article Otorhinolaryngology

Prevalence and associated factors of aspiration and severe dysphagia in asymptomatic patients in the late period after open partial laryngectomy: a videofluoroscopic evaluation

Andressa Silva de Freitas, Izabella C. Santos, Cristina Furia, Rodrigo Dornelas, Ana Catarina Alves e Silva, Fernando Luiz Dias, Gil F. Salles

Summary: This study evaluated late and asymptomatic patients after open partial horizontal laryngectomy (OPHL) and found that dysphagia is common in these patients. Older age, lower preoperative serum albumin levels, greater postoperative weight loss, and diabetes are associated with a higher risk of severe dysphagia in the late period after OPHL.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

Article Otorhinolaryngology

DIGEST Scale Predictis More Quality of Life Than PAS: the Residue Influence on Supracricoid Laryngectomy

Andressa Silva de Freitas, Guilherme Maia Zica, Mariana Salles, Ana Catarina Alves E Silva, Thiago Huaytalla Silva, Fernando Luiz Dias, Izabella Costa Santos

Summary: The study investigated and compared the relationship between self-reported quality of life and objective assessments of swallowing function in patients undergoing SCL CHEP. The findings showed that swallowing function is crucial for quality of life, with residue potentially being more important than aspiration.

INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY (2022)

Article Otorhinolaryngology

Sentinel lymph node biopsy for early squamous cell carcinoma of the lip and oral cavity: Real-world experience in Brazil

Leandro Luongo Matos, Renato Castro Capuzzo, Paola Andrea Galbiatti Pedruzzi, Terence Farias, Jose Wilson Mourao de Farias, Carlos Takahiro Chone, Hugo Fontan Kohler, Jose Guilherme Vartanian, Fernando Luiz Dias, Eduardo Vieira Couto, Fabio Roberto Pinto, Andre Lopes Carvalho, Luiz Paulo Kowalski

Summary: In a real-world scenario, sentinel lymph node biopsy is shown to be accurate and safe for patients with early lip and oral cavity squamous cell carcinoma, with similar results to elective neck dissection.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

Article Oncology

Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer-INCAGI004

Rodrigo Otavio Araujo, Fernando Meton Vieira, Ana Paula Victorino, Claudia Torres, Ivanir Martins, Simone Guaraldi, Marcus Valadao, Eduardo Linhares, Carlos Gil Ferreira, Luiz Claudio Thuler

Summary: This study aimed to compare the impact of two different neoadjuvant chemoradiotherapy (neoCRT) regimens on the quality of life (QOL) in patients with locally advanced rectal cancer. The results showed that the QOL was equivalent between the two treatment groups after neoCRT, with the exception of better micturition problems, gastrointestinal problems, defecation problems, and sexual satisfaction in the capecitabine group. Overall, the QOL improved after neoCRT but decreased following rectal resection, returning to basal levels at late evaluation. Fecal incontinence was high after sphincter preservation.

SUPPORTIVE CARE IN CANCER (2022)

Review Oncology

Evaluating new treatments for anaplastic thyroid cancer

Andres Coca-Pelaz, Juan P. Rodrigo, Fernando Lopez, Jatin P. Shah, Carl E. Silver, Abir Al Ghuzlan, C. Willemien Menke-van der Houven Van Oordt, Robert C. Smallridge, Ashok R. Shaha, Peter Angelos, William M. Mendenhall, Cesare Piazza, Kerry D. Olsen, June Corry, Ralph P. Tufano, Alvaro Sanabria, Sandra Nuyts, Cherie-Ann Nathan, Vincent Vander Poorten, Fernando Luiz Dias, Carlos Suarez, Nabil F. Saba, Pim de Graaf, Michelle D. Williams, Alessandra Rinaldo, Alfio Ferlito

Summary: Anaplastic thyroid cancer is a deadly disease with limited treatment options. Recent advancements in personalized medicine and combination therapy have shown promising results, particularly in targeting specific genetic profiles. Although average survival has improved, there is still a need for further improvement.

EXPERT REVIEW OF ANTICANCER THERAPY (2022)

Review Oncology

Minor Salivary Gland Cancer of the Head and Neck: A Review of Epidemiologic Aspects, Prognostic Factors, and Outcomes

Paula Fatturi Moretz-sohn, Fernando Luiz Dias, Caroline Mafra de Carvalho Marques

Summary: The purpose of this study is to clarify the incidence, epidemiology, predictive factors, and outcome-based survival in a large cohort of patients with minor salivary gland carcinomas (MiSGC) of the head and neck treated at the Brazilian National Cancer Institute (BNCI) over a 20-year period by comparing and associating the results of current articles on the world stage.

CURRENT ONCOLOGY REPORTS (2023)

Article Health Care Sciences & Services

Discrepancies Between the Cost of Advanced Lung Cancer Treatment and How Much Is Reimbursed by the Brazilian Public Healthcare System

Marina Kelner, Bruna Carvalho da Silva, Tatiane Montella, Pedro Nazareth Aguiar, Gilberto Lopes, Carlos G. Ferreira, Pedro De Marchi

Summary: This study compares the cost of treating advanced lung cancer in Brazil with the reimbursement provided by the Brazilian public healthcare system. It finds that the cost of the best treatment available is significantly higher than the amount reimbursed by the system.

VALUE IN HEALTH REGIONAL ISSUES (2023)

Article Oncology

Real-World Evidence of Health Outcomes Related to Lung Stereotactic Body Radiation Therapy in Brazil

Lilian Faroni, Carlos Gil Ferreira, Fabio Moraes, Clarissa Baldotto, Mauro Zukin, Veronica Aran, Luiz Henrique Araujo

Summary: The study examined the real-world outcomes of using SBRT for lung lesions in a Brazilian institution. The results showed that SBRT was effective in achieving high local control rates and had acceptable toxicity for treating malignant lung lesions in Latin America.

JCO GLOBAL ONCOLOGY (2022)

Article Medicine, General & Internal

Sotorasib versus docetaxel for previously treated non-small- cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

Adrianus Johannes de Langen, Melissa L. Johnson, Julien Mazieres, Anne -Marie C. Dingemans, Giannis Mountzios, Miklos Pless, Jurgen Wolf, Martin Schuler, Herve Lena, Ferdinandos Skoulidis, Yasuto Yoneshima, Sang-We Kim, Helena Linardou, Silvia Novello, Anthonie J. van der Wekken, Yuanbin Chen, Solange Peters, Enriqueta Felip, Benjamin J. Solomon, Suresh S. Ramalingam, Christophe Dooms, Colin R. Lindsay, Carlos Gil Ferreira, Normand Blais, Cynthia C. Obiozor, Yang Wang, Bhakti Mehta, Tracy Varrieur, Gataree Ngarmchamnanrith, Bjorn Stollenwerk, David Waterhouse, Luis Paz-Ares

Summary: This study compared the efficacy and safety of Sotorasib with standard-of-care treatment in patients with non-small-cell lung cancer (NSCLC) with the KRASG12C mutation. The results showed that compared to docetaxel, Sotorasib significantly increased progression-free survival and had a more favorable safety profile.

LANCET (2023)

Article Oncology

Partial Laryngectomy for pT4a Laryngeal Cancer: Outcomes and Limits in Selected Cases

Giovanni Succo, Andy Bertolin, Izabela Costa Santos, Martina Tascone, Marco Lionello, Marco Fantini, Andressa Silva de Freitas, Ilaria Bertotto, Andrea Elio Sprio, Giuseppe Sanguineti, Fernando Luiz Dias, Giuseppe Rizzotto, Erika Crosetti

Summary: A study of 134 cases of T4a laryngeal cancer treated with OPHL+/- PORT was conducted, showing that OPHL can be a viable option in selected pT4a LC patients who refuse total laryngectomy.

CANCERS (2023)

Article Otorhinolaryngology

Recipient vessels for free flaps in advanced facial oncologic defects

Bruno Albuquerque Sousa, Fernando Luiz Dias, Marcus A. Acioly de Sousa, Marco Antonio Pinto, Jessica Marquet Silva, Claudio Roberto Cernea

Summary: This study compared the outcomes of microvascular flap reconstruction of mid-face and scalp oncologic defects using superficial temporal and cervical vessels as recipient vessels. The results showed that the patients with superficial temporal recipient vessels had a higher rate of flap loss compared to those with cervical recipient vessels, but the difference was not statistically significant.

BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY (2023)

Article Health Care Sciences & Services

Precision medicine in Thoracic Oncology: understanding disparities to tackle inequities in access

Flavia Amaral Duarte, Pedro Nazareth Aguiar Junior, Rodrigo Dienstmann, Carlos Gil Ferreira

Summary: Precision medicine provides personalized interventions based on patients' or tumors' characteristics, but it faces challenges in becoming a global reality, with the main issue being inequities in access to genomic testing. Disparities exist between regions and populations, and socioeconomic factors play a significant role in this inequality.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2023)

Article Endocrinology & Metabolism

Guidelines from the Brazilian society of surgical oncology regarding indications and technical aspects of neck dissection in papillary, follicular, and medullary thyroid cancers

Terence Farias, Luiz Paulo Kowalski, Fernando Dias, Carlos S. Ritta Barreira, Jose Guilherme Vartanian, Marcos Roberto Tavares, Fernanda Vaisman, Denise Momesso, Alexandre Ferreira Oliveira, Rodrigo Nascimento Pinheiro, Heber Salvador de Castro Ribeiro

Summary: The purpose of these guidelines is to provide specific recommendations for the surgical treatment of neck metastases in patients with papillary, follicular, and medullary thyroid carcinomas. Recommendations were developed based on research of scientific articles and guidelines from international medical societies. The guidelines offer recommendations on when to perform neck dissection, the extent of dissection, and the use of molecular tests.

ARCHIVES OF ENDOCRINOLOGY METABOLISM (2023)

Article Oncology

Long-term outcomes of neo-adjuvant chemotherapy on borderline resectable oral cavity cancers: Real-world data of 3266 patients and implications for clinical practice

Vanita Noronha, Aditya Dhanawat, Vijay Maruti Patil, Nandini Menon, Ajay Kumar Singh, Pankaj Chaturvedi, Prathamesh Pai, Devendra Chaukar, Sarbani Ghosh Laskar, Kumar Prabhash

Summary: Neo-adjuvant chemotherapy has shown long term survival benefits in patients with locally advanced oral cavity squamous cell carcinomas.

ORAL ONCOLOGY (2024)

Article Oncology

Development of machine learning models for the prediction of long-term feeding tube dependence after oral and oropharyngeal cancer surgery

Andrea Costantino, Claudio Sampieri, Gian Marco Pace, Bianca Maria Festa, Luca Cerri, Giorgio Gregory Giordano, Michael Dale, Giuseppe Spriano, Giorgio Peretti, Armando De Virgilio

Summary: This study aimed to predict the necessity of enteral nutrition at 28 days after surgery in patients with head and neck cancers. The results showed that the machine learning models had optimistic accuracy in predicting the need for enteral nutrition, but had moderate sensitivity.

ORAL ONCOLOGY (2024)

Article Oncology

Comprehensive clinical, genome and transcriptomic analysis of primary ghost cell odontogenic carcinoma

Lirui Zhang, Qiaoshi Xu, Zhien Feng

Summary: This study presents a comprehensive clinical, genomic, and transcriptomic analysis of primary ghost cell odontogenic carcinoma (GCOC). The results provide the first comprehensive molecular atlas for primary GCOC, including previously identified CTNNB1 mutation and novel alterations in MAP3K, EP300, and the 22q11.21 region. The transcriptome analysis reveals significant involvement of cytokine-cytokine receptor interaction and the PI3K-Akt signaling pathway. More GCOC cases should be compared to validate these findings for accurate clinical guidance.

ORAL ONCOLOGY (2024)

Article Oncology

Anti-LGALS3BP antibody-drug conjugate treatment induces durable and potent antitumor response in a preclinical model of adenoid cystic carcinoma

Emily Capone, Vittoria Perrotti, Ilaria Cela, Rossano Lattanzio, Lucrezia Togni, Corrado Rubini, Vito Carlo Alberto Caponio, Lorenzo Lo Muzio, Martina Colasante, Francesco Giansanti, Rodolfo Ippoliti, Stefano Iacobelli, Michael J. Wick, Nicole Spardy Burr, Gianluca Sala

Summary: This study explores the potential of galectin-3 binding protein (LGALS3BP) as a novel target for antibody-drug conjugate (ADC) therapy in adenoid cystic carcinoma (ACC). The results show that LGALS3BP is highly expressed in ACC tissues and treatment with anti-LGALS3BP ADC leads to durable tumor growth inhibition in animal models.

ORAL ONCOLOGY (2024)

Article Oncology

Transoral robotic surgery in oropharyngeal squamous cell carcinoma: A comparative study between da Vinci Single-Port and da Vinci Xi systems

Andrea Costantino, Claudio Sampieri, Piero Giuseppe Meliante, Armando De Virgilio, Se-Heon Kim

Summary: This study compares the outcomes of transoral resections using the da Vinci SP and da Vinci Xi systems for oropharyngeal squamous cell carcinoma (OPSCC). The results indicate that the da Vinci SP system has advantages in terms of reduced docking and console times, as well as improved rates of wide negative resection margins. However, there were no significant differences in complication rates or postoperative functional outcomes between the two systems.

ORAL ONCOLOGY (2024)